+1 (704) 266-3234

Global Leuprolide Market Insights And Forecast To 2028

Published on: May 2022 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 125

Leuprolide market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Leuprolide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Subcutaneous
Topical
Segment by Application
Breast Cancer
Endometriosis
Precocious Puberty
Prostate Cancer
Uterine Fibrosis
Other
By Company
TOLMAR PHARMACEUTICALS
Sanofi
Teva
Sandoz (Novartis)
Sun Pharmaceutical
AbbVie
Bayer
Takeda
Beijing Boente Pharmaceutical
Livzon Pharmaceutical
Selleck
Hangzhou Peptide Biochemical
Chengdu Shenguo Biological Pharmaceutical
SciAnda Pharma
Daewoong
GP Pharm
Enteris BioPharma
Chong Kun Dang
Leadiant Biosciences
Hikma Pharmaceuticals
Lee Pharma
Hanall
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leuprolide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Subcutaneous
1.2.3 Topical
1.3 Market by Application
1.3.1 Global Leuprolide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Endometriosis
1.3.4 Precocious Puberty
1.3.5 Prostate Cancer
1.3.6 Uterine Fibrosis
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Leuprolide Market Perspective (2017-2028)
2.2 Leuprolide Growth Trends by Region
2.2.1 Leuprolide Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Leuprolide Historic Market Size by Region (2017-2022)
2.2.3 Leuprolide Forecasted Market Size by Region (2023-2028)
2.3 Leuprolide Market Dynamics
2.3.1 Leuprolide Industry Trends
2.3.2 Leuprolide Market Drivers
2.3.3 Leuprolide Market Challenges
2.3.4 Leuprolide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leuprolide Players by Revenue
3.1.1 Global Top Leuprolide Players by Revenue (2017-2022)
3.1.2 Global Leuprolide Revenue Market Share by Players (2017-2022)
3.2 Global Leuprolide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Leuprolide Revenue
3.4 Global Leuprolide Market Concentration Ratio
3.4.1 Global Leuprolide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leuprolide Revenue in 2021
3.5 Leuprolide Key Players Head office and Area Served
3.6 Key Players Leuprolide Product Solution and Service
3.7 Date of Enter into Leuprolide Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Leuprolide Breakdown Data by Type
4.1 Global Leuprolide Historic Market Size by Type (2017-2022)
4.2 Global Leuprolide Forecasted Market Size by Type (2023-2028)
5 Leuprolide Breakdown Data by Application
5.1 Global Leuprolide Historic Market Size by Application (2017-2022)
5.2 Global Leuprolide Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Leuprolide Market Size (2017-2028)
6.2 North America Leuprolide Market Size by Type
6.2.1 North America Leuprolide Market Size by Type (2017-2022)
6.2.2 North America Leuprolide Market Size by Type (2023-2028)
6.2.3 North America Leuprolide Market Share by Type (2017-2028)
6.3 North America Leuprolide Market Size by Application
6.3.1 North America Leuprolide Market Size by Application (2017-2022)
6.3.2 North America Leuprolide Market Size by Application (2023-2028)
6.3.3 North America Leuprolide Market Share by Application (2017-2028)
6.4 North America Leuprolide Market Size by Country
6.4.1 North America Leuprolide Market Size by Country (2017-2022)
6.4.2 North America Leuprolide Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Leuprolide Market Size (2017-2028)
7.2 Europe Leuprolide Market Size by Type
7.2.1 Europe Leuprolide Market Size by Type (2017-2022)
7.2.2 Europe Leuprolide Market Size by Type (2023-2028)
7.2.3 Europe Leuprolide Market Share by Type (2017-2028)
7.3 Europe Leuprolide Market Size by Application
7.3.1 Europe Leuprolide Market Size by Application (2017-2022)
7.3.2 Europe Leuprolide Market Size by Application (2023-2028)
7.3.3 Europe Leuprolide Market Share by Application (2017-2028)
7.4 Europe Leuprolide Market Size by Country
7.4.1 Europe Leuprolide Market Size by Country (2017-2022)
7.4.2 Europe Leuprolide Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Leuprolide Market Size (2017-2028)
8.2 Asia-Pacific Leuprolide Market Size by Type
8.2.1 Asia-Pacific Leuprolide Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Leuprolide Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Leuprolide Market Share by Type (2017-2028)
8.3 Asia-Pacific Leuprolide Market Size by Application
8.3.1 Asia-Pacific Leuprolide Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Leuprolide Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Leuprolide Market Share by Application (2017-2028)
8.4 Asia-Pacific Leuprolide Market Size by Region
8.4.1 Asia-Pacific Leuprolide Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Leuprolide Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Leuprolide Market Size (2017-2028)
9.2 Latin America Leuprolide Market Size by Type
9.2.1 Latin America Leuprolide Market Size by Type (2017-2022)
9.2.2 Latin America Leuprolide Market Size by Type (2023-2028)
9.2.3 Latin America Leuprolide Market Share by Type (2017-2028)
9.3 Latin America Leuprolide Market Size by Application
9.3.1 Latin America Leuprolide Market Size by Application (2017-2022)
9.3.2 Latin America Leuprolide Market Size by Application (2023-2028)
9.3.3 Latin America Leuprolide Market Share by Application (2017-2028)
9.4 Latin America Leuprolide Market Size by Country
9.4.1 Latin America Leuprolide Market Size by Country (2017-2022)
9.4.2 Latin America Leuprolide Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leuprolide Market Size (2017-2028)
10.2 Middle East & Africa Leuprolide Market Size by Type
10.2.1 Middle East & Africa Leuprolide Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Leuprolide Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Leuprolide Market Share by Type (2017-2028)
10.3 Middle East & Africa Leuprolide Market Size by Application
10.3.1 Middle East & Africa Leuprolide Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Leuprolide Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Leuprolide Market Share by Application (2017-2028)
10.4 Middle East & Africa Leuprolide Market Size by Country
10.4.1 Middle East & Africa Leuprolide Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Leuprolide Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 TOLMAR PHARMACEUTICALS
11.1.1 TOLMAR PHARMACEUTICALS Company Details
11.1.2 TOLMAR PHARMACEUTICALS Business Overview
11.1.3 TOLMAR PHARMACEUTICALS Leuprolide Introduction
11.1.4 TOLMAR PHARMACEUTICALS Revenue in Leuprolide Business (2017-2022)
11.1.5 TOLMAR PHARMACEUTICALS Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Leuprolide Introduction
11.2.4 Sanofi Revenue in Leuprolide Business (2017-2022)
11.2.5 Sanofi Recent Developments
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Leuprolide Introduction
11.3.4 Teva Revenue in Leuprolide Business (2017-2022)
11.3.5 Teva Recent Developments
11.4 Sandoz (Novartis)
11.4.1 Sandoz (Novartis) Company Details
11.4.2 Sandoz (Novartis) Business Overview
11.4.3 Sandoz (Novartis) Leuprolide Introduction
11.4.4 Sandoz (Novartis) Revenue in Leuprolide Business (2017-2022)
11.4.5 Sandoz (Novartis) Recent Developments
11.5 Sun Pharmaceutical
11.5.1 Sun Pharmaceutical Company Details
11.5.2 Sun Pharmaceutical Business Overview
11.5.3 Sun Pharmaceutical Leuprolide Introduction
11.5.4 Sun Pharmaceutical Revenue in Leuprolide Business (2017-2022)
11.5.5 Sun Pharmaceutical Recent Developments
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Leuprolide Introduction
11.6.4 AbbVie Revenue in Leuprolide Business (2017-2022)
11.6.5 AbbVie Recent Developments
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Leuprolide Introduction
11.7.4 Bayer Revenue in Leuprolide Business (2017-2022)
11.7.5 Bayer Recent Developments
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Leuprolide Introduction
11.8.4 Takeda Revenue in Leuprolide Business (2017-2022)
11.8.5 Takeda Recent Developments
11.9 Beijing Boente Pharmaceutical
11.9.1 Beijing Boente Pharmaceutical Company Details
11.9.2 Beijing Boente Pharmaceutical Business Overview
11.9.3 Beijing Boente Pharmaceutical Leuprolide Introduction
11.9.4 Beijing Boente Pharmaceutical Revenue in Leuprolide Business (2017-2022)
11.9.5 Beijing Boente Pharmaceutical Recent Developments
11.10 Livzon Pharmaceutical
11.10.1 Livzon Pharmaceutical Company Details
11.10.2 Livzon Pharmaceutical Business Overview
11.10.3 Livzon Pharmaceutical Leuprolide Introduction
11.10.4 Livzon Pharmaceutical Revenue in Leuprolide Business (2017-2022)
11.10.5 Livzon Pharmaceutical Recent Developments
11.11 Selleck
11.11.1 Selleck Company Details
11.11.2 Selleck Business Overview
11.11.3 Selleck Leuprolide Introduction
11.11.4 Selleck Revenue in Leuprolide Business (2017-2022)
11.11.5 Selleck Recent Developments
11.12 Hangzhou Peptide Biochemical
11.12.1 Hangzhou Peptide Biochemical Company Details
11.12.2 Hangzhou Peptide Biochemical Business Overview
11.12.3 Hangzhou Peptide Biochemical Leuprolide Introduction
11.12.4 Hangzhou Peptide Biochemical Revenue in Leuprolide Business (2017-2022)
11.12.5 Hangzhou Peptide Biochemical Recent Developments
11.13 Chengdu Shenguo Biological Pharmaceutical
11.13.1 Chengdu Shenguo Biological Pharmaceutical Company Details
11.13.2 Chengdu Shenguo Biological Pharmaceutical Business Overview
11.13.3 Chengdu Shenguo Biological Pharmaceutical Leuprolide Introduction
11.13.4 Chengdu Shenguo Biological Pharmaceutical Revenue in Leuprolide Business (2017-2022)
11.13.5 Chengdu Shenguo Biological Pharmaceutical Recent Developments
11.14 SciAnda Pharma
11.14.1 SciAnda Pharma Company Details
11.14.2 SciAnda Pharma Business Overview
11.14.3 SciAnda Pharma Leuprolide Introduction
11.14.4 SciAnda Pharma Revenue in Leuprolide Business (2017-2022)
11.14.5 SciAnda Pharma Recent Developments
11.15 Daewoong
11.15.1 Daewoong Company Details
11.15.2 Daewoong Business Overview
11.15.3 Daewoong Leuprolide Introduction
11.15.4 Daewoong Revenue in Leuprolide Business (2017-2022)
11.15.5 Daewoong Recent Developments
11.16 GP Pharm
11.16.1 GP Pharm Company Details
11.16.2 GP Pharm Business Overview
11.16.3 GP Pharm Leuprolide Introduction
11.16.4 GP Pharm Revenue in Leuprolide Business (2017-2022)
11.16.5 GP Pharm Recent Developments
11.17 Enteris BioPharma
11.17.1 Enteris BioPharma Company Details
11.17.2 Enteris BioPharma Business Overview
11.17.3 Enteris BioPharma Leuprolide Introduction
11.17.4 Enteris BioPharma Revenue in Leuprolide Business (2017-2022)
11.17.5 Enteris BioPharma Recent Developments
11.18 Chong Kun Dang
11.18.1 Chong Kun Dang Company Details
11.18.2 Chong Kun Dang Business Overview
11.18.3 Chong Kun Dang Leuprolide Introduction
11.18.4 Chong Kun Dang Revenue in Leuprolide Business (2017-2022)
11.18.5 Chong Kun Dang Recent Developments
11.19 Leadiant Biosciences
11.19.1 Leadiant Biosciences Company Details
11.19.2 Leadiant Biosciences Business Overview
11.19.3 Leadiant Biosciences Leuprolide Introduction
11.19.4 Leadiant Biosciences Revenue in Leuprolide Business (2017-2022)
11.19.5 Leadiant Biosciences Recent Developments
11.20 Hikma Pharmaceuticals
11.20.1 Hikma Pharmaceuticals Company Details
11.20.2 Hikma Pharmaceuticals Business Overview
11.20.3 Hikma Pharmaceuticals Leuprolide Introduction
11.20.4 Hikma Pharmaceuticals Revenue in Leuprolide Business (2017-2022)
11.20.5 Hikma Pharmaceuticals Recent Developments
11.21 Lee Pharma
11.21.1 Lee Pharma Company Details
11.21.2 Lee Pharma Business Overview
11.21.3 Lee Pharma Leuprolide Introduction
11.21.4 Lee Pharma Revenue in Leuprolide Business (2017-2022)
11.21.5 Lee Pharma Recent Developments
11.22 Hanall
11.22.1 Hanall Company Details
11.22.2 Hanall Business Overview
11.22.3 Hanall Leuprolide Introduction
11.22.4 Hanall Revenue in Leuprolide Business (2017-2022)
11.22.5 Hanall Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Leuprolide Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Subcutaneous
Table 3. Key Players of Topical
Table 4. Global Leuprolide Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Leuprolide Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Leuprolide Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Leuprolide Market Share by Region (2017-2022)
Table 8. Global Leuprolide Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Leuprolide Market Share by Region (2023-2028)
Table 10. Leuprolide Market Trends
Table 11. Leuprolide Market Drivers
Table 12. Leuprolide Market Challenges
Table 13. Leuprolide Market Restraints
Table 14. Global Leuprolide Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Leuprolide Revenue Share by Players (2017-2022)
Table 16. Global Top Leuprolide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leuprolide as of 2021)
Table 17. Ranking of Global Top Leuprolide Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Leuprolide Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Leuprolide Product Solution and Service
Table 21. Date of Enter into Leuprolide Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Leuprolide Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Leuprolide Revenue Market Share by Type (2017-2022)
Table 25. Global Leuprolide Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Leuprolide Revenue Market Share by Type (2023-2028)
Table 27. Global Leuprolide Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Leuprolide Revenue Share by Application (2017-2022)
Table 29. Global Leuprolide Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Leuprolide Revenue Share by Application (2023-2028)
Table 31. North America Leuprolide Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Leuprolide Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Leuprolide Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Leuprolide Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Leuprolide Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Leuprolide Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Leuprolide Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Leuprolide Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Leuprolide Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Leuprolide Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Leuprolide Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Leuprolide Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Leuprolide Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Leuprolide Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Leuprolide Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Leuprolide Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Leuprolide Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Leuprolide Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Leuprolide Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Leuprolide Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Leuprolide Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Leuprolide Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Leuprolide Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Leuprolide Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Leuprolide Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Leuprolide Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Leuprolide Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Leuprolide Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Leuprolide Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Leuprolide Market Size by Country (2023-2028) & (US$ Million)
Table 61. TOLMAR PHARMACEUTICALS Company Details
Table 62. TOLMAR PHARMACEUTICALS Business Overview
Table 63. TOLMAR PHARMACEUTICALS Leuprolide Product
Table 64. TOLMAR PHARMACEUTICALS Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 65. TOLMAR PHARMACEUTICALS Recent Developments
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Leuprolide Product
Table 69. Sanofi Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 70. Sanofi Recent Developments
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Leuprolide Product
Table 74. Teva Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 75. Teva Recent Developments
Table 76. Sandoz (Novartis) Company Details
Table 77. Sandoz (Novartis) Business Overview
Table 78. Sandoz (Novartis) Leuprolide Product
Table 79. Sandoz (Novartis) Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 80. Sandoz (Novartis) Recent Developments
Table 81. Sun Pharmaceutical Company Details
Table 82. Sun Pharmaceutical Business Overview
Table 83. Sun Pharmaceutical Leuprolide Product
Table 84. Sun Pharmaceutical Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 85. Sun Pharmaceutical Recent Developments
Table 86. AbbVie Company Details
Table 87. AbbVie Business Overview
Table 88. AbbVie Leuprolide Product
Table 89. AbbVie Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 90. AbbVie Recent Developments
Table 91. Bayer Company Details
Table 92. Bayer Business Overview
Table 93. Bayer Leuprolide Product
Table 94. Bayer Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 95. Bayer Recent Developments
Table 96. Takeda Company Details
Table 97. Takeda Business Overview
Table 98. Takeda Leuprolide Product
Table 99. Takeda Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 100. Takeda Recent Developments
Table 101. Beijing Boente Pharmaceutical Company Details
Table 102. Beijing Boente Pharmaceutical Business Overview
Table 103. Beijing Boente Pharmaceutical Leuprolide Product
Table 104. Beijing Boente Pharmaceutical Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 105. Beijing Boente Pharmaceutical Recent Developments
Table 106. Livzon Pharmaceutical Company Details
Table 107. Livzon Pharmaceutical Business Overview
Table 108. Livzon Pharmaceutical Leuprolide Product
Table 109. Livzon Pharmaceutical Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 110. Livzon Pharmaceutical Recent Developments
Table 111. Selleck Company Details
Table 112. Selleck Business Overview
Table 113. Selleck Leuprolide Product
Table 114. Selleck Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 115. Selleck Recent Developments
Table 116. Hangzhou Peptide Biochemical Company Details
Table 117. Hangzhou Peptide Biochemical Business Overview
Table 118. Hangzhou Peptide Biochemical Leuprolide Product
Table 119. Hangzhou Peptide Biochemical Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 120. Hangzhou Peptide Biochemical Recent Developments
Table 121. Chengdu Shenguo Biological Pharmaceutical Company Details
Table 122. Chengdu Shenguo Biological Pharmaceutical Business Overview
Table 123. Chengdu Shenguo Biological Pharmaceutical Leuprolide Product
Table 124. Chengdu Shenguo Biological Pharmaceutical Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 125. Chengdu Shenguo Biological Pharmaceutical Recent Developments
Table 126. SciAnda Pharma Company Details
Table 127. SciAnda Pharma Business Overview
Table 128. SciAnda Pharma Leuprolide Product
Table 129. SciAnda Pharma Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 130. SciAnda Pharma Recent Developments
Table 131. Daewoong Company Details
Table 132. Daewoong Business Overview
Table 133. Daewoong Leuprolide Product
Table 134. Daewoong Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 135. Daewoong Recent Developments
Table 136. GP Pharm Company Details
Table 137. GP Pharm Business Overview
Table 138. GP Pharm Leuprolide Product
Table 139. GP Pharm Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 140. GP Pharm Recent Developments
Table 141. Enteris BioPharma Company Details
Table 142. Enteris BioPharma Business Overview
Table 143. Enteris BioPharma Leuprolide Product
Table 144. Enteris BioPharma Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 145. Enteris BioPharma Recent Developments
Table 146. Chong Kun Dang Company Details
Table 147. Chong Kun Dang Business Overview
Table 148. Chong Kun Dang Leuprolide Product
Table 149. Chong Kun Dang Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 150. Chong Kun Dang Recent Developments
Table 151. Leadiant Biosciences Company Details
Table 152. Leadiant Biosciences Business Overview
Table 153. Leadiant Biosciences Leuprolide Product
Table 154. Leadiant Biosciences Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 155. Leadiant Biosciences Recent Developments
Table 156. Hikma Pharmaceuticals Company Details
Table 157. Hikma Pharmaceuticals Business Overview
Table 158. Hikma Pharmaceuticals Leuprolide Product
Table 159. Hikma Pharmaceuticals Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 160. Hikma Pharmaceuticals Recent Developments
Table 161. Lee Pharma Company Details
Table 162. Lee Pharma Business Overview
Table 163. Lee Pharma Leuprolide Product
Table 164. Lee Pharma Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 165. Lee Pharma Recent Developments
Table 166. Hanall Company Details
Table 167. Hanall Business Overview
Table 168. Hanall Leuprolide Product
Table 169. Hanall Revenue in Leuprolide Business (2017-2022) & (US$ Million)
Table 170. Hanall Recent Developments
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leuprolide Market Share by Type: 2021 VS 2028
Figure 2. Subcutaneous Features
Figure 3. Topical Features
Figure 4. Global Leuprolide Market Share by Application: 2021 VS 2028
Figure 5. Breast Cancer Case Studies
Figure 6. Endometriosis Case Studies
Figure 7. Precocious Puberty Case Studies
Figure 8. Prostate Cancer Case Studies
Figure 9. Uterine Fibrosis Case Studies
Figure 10. Other Case Studies
Figure 11. Leuprolide Report Years Considered
Figure 12. Global Leuprolide Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Leuprolide Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Leuprolide Market Share by Region: 2021 VS 2028
Figure 15. Global Leuprolide Market Share by Players in 2021
Figure 16. Global Top Leuprolide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leuprolide as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Leuprolide Revenue in 2021
Figure 18. North America Leuprolide Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Leuprolide Market Size Market Share by Type (2017-2028)
Figure 20. North America Leuprolide Market Size Market Share by Application (2017-2028)
Figure 21. North America Leuprolide Market Size Share by Country (2017-2028)
Figure 22. United States Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Leuprolide Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Leuprolide Market Size Market Share by Type (2017-2028)
Figure 26. Europe Leuprolide Market Size Market Share by Application (2017-2028)
Figure 27. Europe Leuprolide Market Size Share by Country (2017-2028)
Figure 28. Germany Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Leuprolide Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Leuprolide Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Leuprolide Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Leuprolide Market Size Share by Region (2017-2028)
Figure 38. China Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Leuprolide Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Leuprolide Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Leuprolide Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Leuprolide Market Size Share by Country (2017-2028)
Figure 48. Mexico Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Leuprolide Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Leuprolide Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Leuprolide Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Leuprolide Market Size Share by Country (2017-2028)
Figure 54. Turkey Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Leuprolide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. TOLMAR PHARMACEUTICALS Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 58. Sanofi Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 59. Teva Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 60. Sandoz (Novartis) Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 61. Sun Pharmaceutical Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 62. AbbVie Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 63. Bayer Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 64. Takeda Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 65. Beijing Boente Pharmaceutical Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 66. Livzon Pharmaceutical Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 67. Selleck Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 68. Hangzhou Peptide Biochemical Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 69. Chengdu Shenguo Biological Pharmaceutical Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 70. SciAnda Pharma Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 71. Daewoong Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 72. GP Pharm Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 73. Enteris BioPharma Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 74. Chong Kun Dang Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 75. Leadiant Biosciences Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 76. Hikma Pharmaceuticals Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 77. Lee Pharma Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 78. Hanall Revenue Growth Rate in Leuprolide Business (2017-2022)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.